NYSE · RTO
Rentokil Initial financials
$20.05−2.20%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '25 Dec 31 | Q4 '24 Dec 31 | Q4 '23 Dec 31 | Q4 '22 Dec 31 |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Gross margin | — | — | — | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| Net margin | — | — | — | — |
| Diluted EPS | — | — | — | — |
| EBITDA | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating cash flow | — | — | — | — |
| Free cash flow | — | — | — | — |
| Diluted shares | 2,535.0M | 2,528.0M | 2,527.0M | 2,014.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Cash & equivalents | $2.32B | $1.16B | $1.99B | $2.63B |
| Short-term investments | $2.0M | $1.0M | $1.0M | $1.2M |
| Total debt | $5.61B | $4.67B | $5.55B | $6.06B |
| Total assets | $14.43B | $13.21B | $14.17B | $14.45B |
| Total liabilities | $8.94B | $7.92B | $8.96B | $9.49B |
| Shareholders' equity | $5.49B | $5.29B | $5.21B | $4.96B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology